New Draft Guidance From US FDA Discusses Trials For Novel Diabetes Treatments
The document discusses feasibility studies on devices that use therapies like neurostimulation or changes to the small intestine to better control blood glucose levels in people with type 2 diabetes.
You may also be interested in...
The series F financing will allow the company to expand clinical research supporting its unique duodenal mucosal resurfacing approach to treating metabolic disease at its source.
Virtual and in-person events are planned for Washington, DC, and Minneapolis, MN, during the trade group gathering.
The US patent office has upheld all seven patents at issue, with the verdict on the final three having come on 22 September.